pharmaphorum

Where others missed, AZ's IL-33 drug hits the mark in COPD

AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...
FierceBiotech

AstraZeneca delivers dream result as phase 3 COPD hits breathe life into class rocked by flops

AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has hit the mark in a pair of phase 3 trials, delivering broad efficacy with a mechanism that yielded mixed data for Roche and ...
EurekAlert!

World COPD Day: November 19, 2025

In support of World COPD Day on November 19, the Global Initiative for Chronic Obstructive Lung Disease (GOLD), is drawing attention to the importance of correctly diagnosing COPD earlier - with the ...
phillyvoice.com

COPD affects more than smokers — and Philadelphia’s air quality makes awareness critical

Chronic obstructive pulmonary disease, or COPD, is often thought of as a condition that only affects longtime smokers. In reality, the disease reaches far beyond that group. Women are ...
CNN

This lung disease can be dangerous for younger people, too

Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...
Medical Xpress

Unexpected COPD relief: Lung fibrosis drug outperforms steroids in pre-clinical model

Researchers have found a promising treatment breakthrough for chronic obstructive pulmonary disease (COPD) that avoids many of the drawbacks of current drugs, and it has come from an unexpected place.
Science Daily

Unusual carbon build-up found in lungs of COPD patients

Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger and ...
WebMD

FDA OKs Nucala for Hard-to-Treat COPD

May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD). It is the second biologic therapy approved for the condition, following the ...
Medscape

Summer Heat and COPD: Managing Respiratory Risks in Rising Temperatures

For some patients with chronic obstructive pulmonary disease (COPD), summer can be one of the most stressful times of the year. Not only is allergy season in full swing, but rising temperatures and ...
Medscape

It’s Time to Recognize COPD as a Women’s Health Issue

Over the next 25 years, the global prevalence of chronic obstructive pulmonary disease (COPD) is expected to grow by as much as 23%. Importantly, a majority of these cases are projected to occur in ...
Healio

Patients with COPD plus depression or anxiety experience greater disease burden

Please provide your email address to receive an email when new articles are posted on . Patients with COPD underwent the Mini-International Neuropsychiatric Interview. Receipt of mental health ...